AI-GPE Lab中文
Datasets“[Center for Translational Data Science at The University of Chicago] (https://ctds.uchicago.edu/)”

Exceptional Responders Initiative

Abstract

The Exceptional Responders Initiative is a pilot study to investigate the underlying molecular factors driving exceptional treatment responses of cancer patients to drug therapies. Study researchers will examine molecular profiles of tumors from patients either enrolled in a clinical trial for an investigational drug(s) and who achieved an exceptional response relative to other trial participants, or who achieved an exceptional response to a non-investigational chemotherapy. An exceptional response is defined as achievement of either a complete response or a partial response for at least 6 months duration in a trial or treatment where the ove

Catalogue metadata

Record ID
AISLI-R-632A0C9F5D647FEF79D4
Type
Datasets
Source catalogue
registry.opendata.aws
Thème
生命科学与生物医学
Conditions d’utilisation
NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies